Excerpt from ParasomniasSynonyms, Key Words, and Related Terms: nightmare disorder, sleep terror disorder, sleepwalking disorder, rapid eye movement sleep behavior disorder, REM sleep behavior disorder, non–rapid eye movement, NREM, restless legs syndrome, RLS, periodic limb movement disorder, PLMD, dyssomnias, sleep drunkenness, microsleeps Please click here to view the full topic text: ParasomniasBackgroundParasomnias are disorders characterized by undesirable motor, verbal, or experiential phenomenon occurring in association with sleep, specific stages of sleep, or sleep-awake transition phases. Parasomnias may be categorized as (1) primary parasomnias, which are the disorders of sleep states and are further classified according to the sleep state of origin, rapid eye movement (REM), or non–rapid eye movement (NREM) or (2) secondary parasomnias, which are disorders of other organ systems that may manifest during sleep, eg, seizures, respiratory dyskinesias, arrhythmias, and gastroesophageal reflux. Two major types of primary sleep disorders are described: dyssomnias and parasomnias. Primary sleep disorder is a malady of sleep that does not appear to be secondary to a physical or mental illness and is not substance-induced. Unlike dyssomnias, which are characterized by abnormal sleep quality, including initiation, maintenance, duration, timing, and amount of sleep, parasomnias are distinguished by deviant behavioral and/or physiologic events. These abnormalities/events are reliably associated with either the sleep/wake interface or certain sleep stages. Additionally, parasomnias manifest by activation of systems, such as the autonomic nervous system, or programs, such as cognitive, behavioral, or motor program stimulation. The parasomnias have been subdivided according to 2 major classification schemes, the American Psychiatric Association's Diagnostic Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) and the American Sleep Disorders Association's International Classification of Sleep Disorders (ICSD). Four major types of parasomnias are included in the DSM-IV-TR. They include (1) nightmare disorder, (2) sleep terror disorder, (3) sleepwalking disorder, and (4) parasomnias not otherwise specified. However, the ICSD subdivides the parasomnias into 3 groups according to the sleep state of origin. They include (1) REM, (2) NREM, and (3) miscellaneous (ie, not respecting the sleep state). The 5 disorders that are primarily discussed in this article are nightmare disorder, sleep terror disorder, sleepwalking disorder, REM sleep behavior disorder, restless legs syndrome (RLS), and periodic limb movement disorder (PLMD). Nightmare disorder: Also called dream anxiety attacks, these are frightening dreams that occur during REM sleep and are associated with tachycardia, tachypnea, diaphoresis, and arousal. Complete alertness and subsequent recollection of the dreams differentiates nightmares from sleep terrors. Note that nightmares are another form of dreams except with documented emotional and physiological consequences. Sleep terror disorder: Sleep terror is a disorder of arousal that primarily occurs during stages III and IV of NREM sleep. Sleep terror manifests as extreme panic and a loud scream during sleep, followed by motor activities such as hitting objects or moving in and out of the bedroom. Subsequent recollection of these episodes either does not occur or is partial. Sleepwalking disorder: Again, this disorder arises from slow-wave stages of NREM sleep. The subject performs complex automatic behaviors, such as wandering aimlessly, carrying objects, going outdoors, and performing other activities of varying complexity and duration. REM sleep behavior disorder: REM sleep behavior disorder is dream-enacting behavior that includes talking, yelling, punching, kicking, sitting, jumping out of bed, arm flailing, and grabbing. An acute form may occur during withdrawal from ethanol or sedative-hypnotic drugs. The chronic form presents for evaluation following observations of bed partners. RLS and PLMD: These are common disorders that often may coexist. RLS primarily presents as insomnia, whereas PLMD is a well-recognized cause of excessive daytime somnolence. Nearly all patients with RLS have periodic limb movements, and only a minority of patients with PLMD also have RLS. Two parasomnias recently validated and more extensively described in the literature are (1) somnambulistic sexual behavior, or sexsomnia, and (2) night eating disorder. Sexual behaviors of all types may occur during sleepwalking. Somnambulistic sexual behavior (also called sexsomnia, sleep sex) is considered a variant of sleepwalking disorder. Sexual behavior during a sleep automatism can vary from explicit sexual vocalizations, to violent masturbation, to complex sexual acts including anal, oral, and vaginal penetration. A recent series described 11 patients with distinct behaviors of the sexual nature during sleep. The features are in common with other NREM arousal parasomnias. Medicolegal issues had occurred in a small number of cases. This behavior is more common than previously thought because a significant number of patients with this unusual parasomnia behavior were identified only after specific questions were asked. The night eating syndrome (NES) was first described by Stunkard et al in 1955. No uniform definition of NES has yet been adopted. Evening hyperphagia originally is the main criterion, which implies that the amount of food consumed is excessive at this time of the day. However, definitions vary in terms of the amount of food consumed, the time frame involved, and whether the evening meal (dinner) is included or not. PathophysiologyHuman life encompasses 3 completely different states of existence: wakefulness, REM sleep, and NREM sleep. Sleep is not simply the passive absence of wakefulness; it is an extensive reorganization of CNS activities occurring during sleep. Each state of being is controlled by its unique neuroanatomic, neurophysiologic, and neurochemical association. Wakefulness and REM and NREM sleep states overlap as transition occurs from one state to another. A large number of neural networks, neurotransmitters, and neurochemicals must be recruited concurrently to assert a given state of existence. Dissociation of these states and the admixture of state-determining variables are the mechanisms that set primary sleep parasomnias in motion. For example, intrusion of NREM sleep during wakefulness may produce sleep drunkenness or microsleeps; occurrence of REM sleep during wakefulness generates cataplexy or wakeful dreaming; loss of muscle atonia during REM sleep sets off acting out of dreams, termed REM behavior disorder. The pathophysiology of parasomnias is unknown, although considerable speculation exists about the role of various functional systems in each disorder. Abnormalities in the normal regulation of different phases of sleep may be present. Some disorders, such as sleep terror and sleepwalking disorders, primarily are disturbances of slow-wave sleep, whereas sleep paralysis and REM behavior disorders are those of REM sleep. Others, such as rhythmic movement disorder (eg, head banging) are those of sleep-wake transition. Because the pattern of activation of parasomnias may resemble epilepsy (abrupt onset, confusion, disorientation, and amnesia for the event period), parasomnias originally were considered a form of epilepsy. Gastaut and Broughton's elegant work in 1965 and Broughton's work published in 1968 established the nonepileptic nature of parasomnias. Rapid eye movement sleep behavior disorder The physiologic phenomena that occur during REM sleep can be categorized as tonic and phasic. Tonic phenomena appear throughout an REM period. Examples include electromyographic (EMG) suppression and low-voltage electroencephalography (EEG). The phasic phenomena occur intermittently during an REM period. Examples include rapid eye movements and variability of cardiac cycle and respiratory function. The tonic and phasic processes have been observed to be variously dissociated and recombined across different states. In contrast to wakefulness, which is characterized by consciousness and muscle tone, REM sleep is associated with dreaming and muscle atonia. Generalized atonia of REM sleep probably is caused by active inhibition of motor activity by centers identified to be present in the pons. REM sleep behavior can be experimentally produced in cats by bilateral pontine tegmental lesions, which are associated with the absence of REM atonia. However, in humans, a structural neuropathology is not necessary for REM behavior disorder because most patients do not have an identifiable neurological disorder. Therefore, functional dysregulation by depression of brainstem structures is responsible for atonia. The reduced activity of structures responsible for inhibiting phasic activity in the brain stem further contributes to the clinical manifestations of REM sleep behavior disorder. Restless legs syndrome and periodic limb movement disorder RLS and PLMD may be 2 clinical manifestations of the same CNS dysfunction. The neurophysiological mechanisms responsible for these disorders are not well described. PLMD occurs with a striking periodicity, suggesting that an underlying CNS pacemaker may be operative. Several observations have suggested that PLMD likely originates in the subcortical region and is regulated by rhythmic fluctuations at the brainstem level. Both of these disorders may be the behavioral manifestation of CNS processes that become disinhibited. Patients with these disorders also may have a lower arousal threshold. Polysomnographic recordings exhibit periodic arousing stimuli leading to K complexes, followed by alpha activity, and then leg movements. The neuropharmacological hypothesis supports that an impaired CNS dopaminergic mechanism also may be involved. The deficiency of dopamine binding sites or low concentrations of dopamine and homovanillic acid have been found in several populations who have PLMD. RLS pathology involves the CNS rather than the peripheral nervous system. CNS involvement in RLS is based in the subcortical or brainstem areas of the brain rather than the spinal system. Since clinical evidence clearly points to the responsiveness of RLS to administration of dopamine or dopamine agonists, abnormality of this system likely is responsible for RLS and PLMD.Various conditions commonly associated with secondary RLS such as end-stage renal disease, pregnancy, and gastric surgery are associated with iron insufficiency. These conditions make it difficult for the brain to access iron sufficiently for proper functioning. Iron is stored and transported in the form of ferritin; transferrin transports iron into the cells through the transferrin receptor. When iron is low, ferritin is decreased, but transferrin levels are increased. Cerebrospinal fluid (CSF) and serum from patients with RLS have lower CSF ferritin levels and higher CSF transferrin levels. Low ferritin levels correlated with RLS severity. Furthermore, a connection may exist between iron insufficiency and dopamine pathology in RLS. Single-photon emission computed tomography (SPECT) studies of the brain have identified defects in striatal dopamine D2 receptors. Other studies have pointed out an abnormality of the endogenous opioid system and abnormalities in iron metabolism with ferritin deficiency. Recent studies have reported low tissue iron content in substantia nigra and red nuclei on brain MRI scans of RLS patients. Consequently, interactions between the opioid and dopamine systems that occur in the basal ganglia, brainstem, and spinal cord contribute to the genesis of RLS and PLMD. FrequencyUnited States
InternationalThe prevalence rates are not known to be any different from US rates. Mortality/Morbidity
Race
Sex
Age
Please click here to view the full topic text: Parasomnias |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |